...
首页> 外文期刊>Human Molecular Genetics >Sequencing analysis of OMI/HTRA2 shows previously reported pathogenic mutations in neurologically normal controls.
【24h】

Sequencing analysis of OMI/HTRA2 shows previously reported pathogenic mutations in neurologically normal controls.

机译:OMI / HTRA2的测序分析显示先前报道的神经系统正常对照中的致病性突变。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

A novel heterozygous non-synonymous mutation and a novel polymorphism in OMI/HTRA2 locus have been associated with Parkinson's disease (PD) in a German population. In an attempt to replicate these results in an independent population, we analyzed the entire coding region of OMI/HTRA2 in a series of 644 North American PD cases with both young- and late-onset disease and in 828 North American neurologically normal controls. Our results show that neither of the variants previously related to PD were associated with PD in our cohort and that the risk variants were present in neurologically normal controls.
机译:OMI / HTRA2基因座中的一个新的杂合子非同义突变和一个新的多态性已与德国人群中的帕金森氏病(PD)相关。为了在一个独立人群中复制这些结果,我们分析了644例患有年轻和晚发性疾病的北美PD患者以及828例北美神经系统正常对照中OMI / HTRA2的整个编码区。我们的结果表明,在我们的队列中,以前与PD相关的变异均未与PD相关,并且在神经系统正常对照中存在风险变异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号